The American Diabetes Association (ADA) guidelines recommend GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high cardiovascular risk, or for those requiring additional glucose-lowering beyond metformin
(2026) "Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial" The Lancet 2
March March 28 Product: Akebias Vafseo Indication: Anemia due to chronic kidney disease After a lengthy regulatory battle, the FDA approved Akebia Therapeutics oral treatment vadadustat
Wegovy is designed to be taken weekly, and taking it too early might lead to higher levels of the drug in your system than intended
Specifically, testosterone and SHBG both showed a 23% genetic correlation with body fat, and SHBG [sex hormone-binding globulin] showed a 29% link with whole body fat
